Hsian-Rong Tseng - Publications

Affiliations: 
Biomedical Engineering 0289 University of California, Los Angeles, Los Angeles, CA 
Area:
Biomedical Engineering, Nanotechnology

97 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Court CM, Hou S, Liu L, Winograd P, DiPardo BJ, Liu SX, Chen PJ, Zhu Y, Smalley M, Zhang R, Sadeghi S, Finn RS, Kaldas FM, Busuttil RW, Zhou XJ, ... Tseng HR, et al. Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells. Npj Precision Oncology. 4: 16. PMID 32637655 DOI: 10.1200/Jco.2018.36.4_Suppl.290  0.355
2020 Wang J, Sun N, Lee YT, Ni Y, Koochekpour R, Zhu Y, Tseng HR, Wang S, Jiang L, Zhu H. A circulating tumor cell-based digital assay for the detection of EGFR T790M mutation in advanced non-small cell lung cancer. Journal of Materials Chemistry. B. PMID 32525199 DOI: 10.1039/D0Tb00589D  0.34
2020 Ahn JC, Teng PC, Chen PJ, Posadas E, Tseng HR, Lu SC, Yang JD. Detection of circulating tumor cells and their implications as a novel biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma. Hepatology (Baltimore, Md.). PMID 32017145 DOI: 10.1002/Hep.31165  0.363
2020 Teng P, Jan YJ, Chen J, Kim M, Yao N, Garraway I, Chu GC, Chen P, Wang JJ, Lee Y, Zhu Y, Chung LW, Feng FY, Freeman M, You S, ... Tseng H, et al. Prostate cancer CTC-RNA Assay: A new method for contemporary genomics and precision medicine via liquid biopsy. Journal of Clinical Oncology. 38: 170-170. DOI: 10.1200/Jco.2020.38.6_Suppl.170  0.317
2020 Wang JJ, Teng P, Jan YJ, Chen J, Cook-Wiens G, Yao N, Chu GC, Chen P, Ho H, Yang Y, Lee Y, Huang J, Chung LW, You S, Zhu Y, ... ... Tseng H, et al. Association of very small nuclear circulating tumor cell (vsnCTC) with clinical outcomes in metastatic castration-resistant prostate cancer. Journal of Clinical Oncology. 38: 168-168. DOI: 10.1200/Jco.2020.38.6_Suppl.168  0.404
2020 Wang JJ, Teng P, Jan YJ, Chen J, Cook-Wiens G, Yao N, Chu GC, Chen P, Ho H, Lee Y, Huang J, Li K, Chung LW, Zhu Y, Freeman M, ... ... Tseng H, et al. Circulating tumor cells with small nuclear size: A novel biomarker for survival and clinical outcomes in advanced prostate cancer. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E17512  0.416
2020 Teng P, Jan YJ, Kim M, Chen J, Yoon J, Wang JJ, Chen P, Yao N, Lee Y, Lozano A, Gadilov R, Freeman M, You S, Tseng H, Posadas EM. Development of a circulating tumor cell-based RNA classifier for patients with castration-resistant prostate cancer: CTC-PCS/PAM50. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E17509  0.382
2020 Wang JJ, Teng P, Jan YJ, Chen J, Cook-Wiens G, Yao N, Chu GC, Chen P, Yang Y, Yeo YH, Lee Y, Chung LW, You S, Zhu Y, Freeman MR, ... ... Tseng H, et al. Abstract 4331: Nuclear size of circulating tumor cells is associated with prognosis in metastatic, castration-resistant prostate cancer Endocrinology. DOI: 10.1158/1538-7445.Am2020-4331  0.384
2020 Dong J, Chen J, Smalley M, Zhao M, Ke Z, Zhu Y, Tseng H. Circulating Rare Cells: Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications (Adv. Mater. 1/2020) Advanced Materials. 32: 2070008. DOI: 10.1002/Adma.202070008  0.325
2019 Dong J, Chen JF, Smalley M, Zhao M, Ke Z, Zhu Y, Tseng HR. Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications. Advanced Materials (Deerfield Beach, Fla.). e1903663. PMID 31566837 DOI: 10.1002/Adma.201903663  0.422
2019 Dong J, Jan YJ, Cheng J, Zhang RY, Meng M, Smalley M, Chen PJ, Tang X, Tseng P, Bao L, Huang TY, Zhou D, Liu Y, Chai X, Zhang H, ... ... Tseng HR, et al. Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells. Science Advances. 5: eaav9186. PMID 31392269 DOI: 10.1126/Sciadv.Aav9186  0.425
2019 Dong J, Zhang RY, Sun N, Smalley MD, Wu Z, Zhou A, Chou S, Jan YJA, Yang P, Bao L, Qi D, Tang X, Tseng P, Hua Y, Xu D, ... ... Tseng HR, et al. Bio-Inspired NanoVilli Chips for Enhanced Capture of Tumor-Derived Extracellular Vesicles: Toward Non-Invasive Detection of Gene Alterations in Non-Small Cell Lung Cancer. Acs Applied Materials & Interfaces. PMID 30892008 DOI: 10.1021/Acsami.9B01406  0.425
2019 Chen P, Jan YJ, Teng P, Chen J, Cheng S, Yao N, Reis-Sobreiro M, Lozano A, Gomez A, Freeman M, Tseng H, Posadas EM. A noninvasive prognostic biomarker for metastatic castration-resistant prostate cancer: Very small nuclear circulating tumor cells. Journal of Clinical Oncology. 37: 179-179. DOI: 10.1200/Jco.2019.37.7_Suppl.179  0.394
2019 Jan YJ, Yoon J, Chen J, Chen P, Teng P, Yao N, Cheng S, Lozano A, Freeman M, You S, Tseng H, Posadas EM. A circulating tumor cell RNA assay for dynamic assessment of androgen receptor signaling inhibitors sensitivity in metastatic castration-resistant prostate cancer. Journal of Clinical Oncology. 37: 157-157. DOI: 10.1200/Jco.2019.37.7_Suppl.157  0.373
2019 Teng P, Jan YJ, Yoon J, Chen P, Chen J, Yao N, Cheng S, Lozano A, Freeman M, You S, Tseng H, Posadas EM. A circulating tumor cell specific RNA assay for assessment of androgen receptor signaling inhibitor sensitivity in metastatic castration-resistant prostate cancer. Journal of Clinical Oncology. 37: 5059-5059. DOI: 10.1200/Jco.2019.37.15_Suppl.5059  0.352
2019 Chen P, Jan YJ, Teng P, Chen J, Cheng S, Yao N, Reis-Sobreiro M, Lozano A, Gomez A, Tseng H, Freeman M, Posadas E. Abstract 436: Prediction of aggressive disease in metastatic castration-resistant prostate cancer: The role of very small nuclear circulating tumor cells Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-436  0.372
2019 Teng P, Jan YJ, Yoon J, Chen J, Chen P, Yao N, Cheng S, Lozano A, Freeman MR, You S, Tseng H, Posadas EM. Abstract 453: A circulating tumor cell assay for dynamic assessment of drug sensitivity in metastatic castration-resistant prostate cancer Cancer Research. 79: 453-453. DOI: 10.1158/1538-7445.Am2019-453  0.394
2019 Chen P, Teng P, Zhu Y, Jan YJ, Smalley M, Afshar Y, Chen L, Pisarska MD, Tseng H. Noninvasive Prenatal Diagnostics: Recent Developments Using Circulating Fetal Nucleated Cells Current Obstetrics and Gynecology Reports. 8: 1-8. DOI: 10.1007/S13669-019-0254-X  0.309
2018 Reis-Sobreiro M, Chen JF, Novitskaya T, You S, Morley S, Steadman K, Kaur Gill N, Eskaros A, Rotinen M, Chu CY, Chung LWK, Tanaka H, Yang W, Knudsen BS, Tseng HR, et al. Emerin deregulation links nuclear shape instability to metastatic potential. Cancer Research. PMID 30154147 DOI: 10.1158/0008-5472.Can-18-0608  0.36
2018 Yao N, Jan YJ, Cheng S, Chen JF, Chung LW, Tseng HR, Posadas EM. Structure and function analysis in circulating tumor cells: using nanotechnology to study nuclear size in prostate cancer. American Journal of Clinical and Experimental Urology. 6: 43-54. PMID 29666832  0.307
2018 Court CM, Hou S, Winograd P, Segel NH, Li QW, Zhu Y, Sadeghi S, Finn RS, Ganapathy E, Song M, French SW, Naini BV, Sho S, Kaldas FM, Busuttil RW, ... ... Tseng HR, et al. A Novel Multimarker Assay for the Phenotypic Profiling of Circulating Tumor Cells in Hepatocellular Carcinoma. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. PMID 29624843 DOI: 10.1002/Lt.25062  0.322
2018 Jan YJ, Chen JF, Zhu Y, Lu YT, Chen SH, Chung H, Smalley M, Huang YW, Dong J, Yu HH, Tomlinson JS, Hou S, Agopian VG, Posadas EM, Tseng HR. NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells. Advanced Drug Delivery Reviews. PMID 29551650 DOI: 10.1016/J.Addr.2018.03.006  0.472
2018 Xu X, Hou S, Wattanatorn N, Wang F, Yang Q, Zhao C, Yu X, Tseng HR, Jonas SJ, Weiss PS. Precision-Guided Nanospears for Targeted and High-Throughput Intracellular Gene Delivery. Acs Nano. PMID 29536729 DOI: 10.1021/Acsnano.8B00763  0.309
2018 Salem AF, Wang S, Billet S, Chen JF, Udompholkul P, Gambini L, Baggio C, Tseng HR, Posadas EM, Bhowmick NA, Pellecchia M. A potent EphA2 agonistic peptide-drug conjugate reduces circulating cancer cells and metastases in breast cancer models. Journal of Medicinal Chemistry. PMID 29470068 DOI: 10.1021/Acs.Jmedchem.7B01837  0.337
2018 Court CM, Ankeny JS, Sho S, Winograd P, Hou S, Song M, Wainberg ZA, Girgis MD, Graeber TG, Agopian VG, Tseng HR, Tomlinson JS. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer. Annals of Surgical Oncology. PMID 29442211 DOI: 10.1245/S10434-017-6290-8  0.385
2018 Jan YJ, Chen J, You S, Yao N, Cheng S, Freeman M, Tseng H, Posadas EM. NanoVelcro CTC purification systems for expressional analysis of circulating tumor cells from prostate cancer patients. Journal of Clinical Oncology. 36: 295-295. DOI: 10.1200/Jco.2018.36.6_Suppl.295  0.424
2018 Jan YJ, You S, Yoon J, Chen J, Yao N, Cheng S, Freeman M, Tseng H, Posadas EM. Dynamic variations in gene expressions of circulating tumor cells in metastatic castration-resistant prostate cancer patients in response to androgen receptor signaling inhibitors. Journal of Clinical Oncology. 36: e17063-e17063. DOI: 10.1200/Jco.2018.36.15_Suppl.E17063  0.345
2018 Jan YJ, Chen J, You S, Yoon J, Yao N, Cheng S, Freeman MR, Tseng H, Posadas EM. Abstract 1578: NanoVelcro CTC Purification Systems for expressional analysis of circulating tumor cells from prostate cancer patients Cancer Research. 78: 1578-1578. DOI: 10.1158/1538-7445.Am2018-1578  0.415
2018 Shen M, Chen J, Luo C, Lee S, Li C, Yang Y, Tsai Y, Ho B, Bao L, Lee T, Jan YJ, Zhu Y, Cheng S, Feng FY, Chen P, ... ... Tseng H, et al. RNA Biomarkers: Glycan Stimulation Enables Purification of Prostate Cancer Circulating Tumor Cells on PEDOT NanoVelcro Chips for RNA Biomarker Detection (Adv. Healthcare Mater. 3/2018) Advanced Healthcare Materials. 7: 1870013. DOI: 10.1002/Adhm.201870013  0.356
2017 Shen MY, Chen JF, Luo CH, Lee S, Li CH, Yang YL, Tsai YH, Ho BC, Bao LR, Lee TJ, Jan YJ, Zhu YZ, Cheng S, Feng FY, Chen P, ... ... Tseng HR, et al. Glycan Stimulation Enables Purification of Prostate Cancer Circulating Tumor Cells on PEDOT NanoVelcro Chips for RNA Biomarker Detection. Advanced Healthcare Materials. PMID 28892262 DOI: 10.1002/Adhm.201700701  0.421
2017 Hou S, Chen JF, Song M, Zhu Y, Jan YJ, Chen SH, Weng TH, Ling DA, Chen SF, Ro T, Liang AJ, Lee T, Jin H, Li M, Liu L, ... ... Tseng HR, et al. Imprinted NanoVelcro Microchips for Isolation and Characterization of Circulating Fetal Trophoblasts: toward Noninvasive Prenatal Diagnostics. Acs Nano. PMID 28721719 DOI: 10.1021/Acsnano.7B03073  0.309
2017 Sho S, Court CM, Winograd P, Lee S, Hou S, Graeber TG, Tseng HR, Tomlinson JS. Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications. Bmc Cancer. 17: 457. PMID 28666423 DOI: 10.1186/S12885-017-3447-6  0.342
2017 Chen JF, Lu YT, Cheng S, Tseng HR, Figlin RA, Posadas EM. Circulating tumor cells in prostate cancer: beyond enumeration. Clinical Advances in Hematology & Oncology : H&O. 15: 63-73. PMID 28212371  0.315
2017 Sho S, Court CM, Kim S, Braxton DR, Hou S, Muthusamy VR, Watson RR, Sedarat A, Tseng HR, Tomlinson JS. Digital PCR Improves Mutation Analysis in Pancreas Fine Needle Aspiration Biopsy Specimens. Plos One. 12: e0170897. PMID 28125707 DOI: 10.1371/Journal.Pone.0170897  0.378
2017 Posadas EM, Chen J, Tripathi M, Lu Y, Montes A, Go A, Ureno A, Cavassani KA, Sievert M, Rogatko A, Limvorasak S, Oppenheim A, Moldawer NP, Chung LW, Bhowmick N, ... Tseng H, et al. Circulating tumor cell subsets and macrophage polarization to predict efficacy of cabozantinib in advanced prostate cancer with visceral metastases. Journal of Clinical Oncology. 35: 5031-5031. DOI: 10.1200/Jco.2017.35.15_Suppl.5031  0.381
2017 Chen J, Shen M, Luo C, Cheng S, Lee S, Hou S, Posadas EM, Tseng H, Yu H. Abstract 3780: Bio-competition-based smart NanoVelcro Chip for isolation and gene expression analysis of circulating tumor cells from prostate cancer patients Cancer Research. 77: 3780-3780. DOI: 10.1158/1538-7445.Am2017-3780  0.436
2016 Cheng S, Chen JF, Lu YT, Chung LWK, Tseng HR, Posadas EM. Applications of circulating tumor cells for prostate cancer. Asian Journal of Urology. 3: 254-259. PMID 29264193 DOI: 10.1016/J.Ajur.2016.09.004  0.406
2016 Wang R, Chu GCY, Mrdenovic S, Annamalai AA, Hendifar AE, Nissen NN, Tomlinson JS, Lewis M, Palanisamy N, Tseng HR, Posadas EM, Freeman MR, Pandol SJ, Zhau HE, Chung LWK. Cultured circulating tumor cells and their derived xenografts for personalized oncology. Asian Journal of Urology. 3: 240-253. PMID 29264192 DOI: 10.1016/J.Ajur.2016.08.005  0.424
2016 Liu S, Tian Z, Zhang L, Hou S, Hu S, Wu J, Jing Y, Sun H, Yu F, Zhao L, Wang R, Tseng HR, Zhau HE, Chung LW, Wu K, et al. Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients. Oncotarget. PMID 27494883 DOI: 10.18632/Oncotarget.10979  0.397
2016 Nair BG, Hagiwara K, Ueda M, Yu HH, Tseng HR, Ito Y. High Density of Aligned Nanowire Treated with Polydopamine for Efficient Gene Silencing by siRNA According to Cell Membrane Perturbation. Acs Applied Materials & Interfaces. PMID 27420034 DOI: 10.1021/Acsami.6B04913  0.308
2016 Chen JF, Zhu Y, Lu YT, Hodara E, Hou S, Agopian VG, Tomlinson JS, Posadas EM, Tseng HR. Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells. Theranostics. 6: 1425-39. PMID 27375790 DOI: 10.7150/Thno.15359  0.437
2016 Court CM, Ankeny JS, Sho S, Hou S, Li Q, Hsieh C, Song M, Liao X, Rochefort MM, Wainberg Z, Graeber TG, Tseng HR, Tomlinson JS. Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer. The Journal of Molecular Diagnostics : Jmd. PMID 27375074 DOI: 10.1016/J.Jmoldx.2016.03.006  0.343
2016 He W, Xu D, Wang Z, Xiang X, Tang B, Li S, Hou M, Zhang Y, Chen JF, Lin M, Wang L, Hou S, Tseng HR, Kuang M, Ke ZF. Detecting ALK-rearrangement of CTC enriched by nanovelcro chip in advanced NSCLC patients. Oncotarget. PMID 27029032 DOI: 10.18632/Oncotarget.8305  0.352
2016 Liu Y, Du J, Choi JS, Chen KJ, Hou S, Yan M, Lin WY, Chen KS, Ro T, Lipshutz GS, Wu L, Shi L, Lu Y, Tseng HR, Wang H. A High-Throughput Platform for Formulating and Screening Multifunctional Nanoparticles Capable of Simultaneous Delivery of Genes and Transcription Factors. Angewandte Chemie (International Ed. in English). 55: 169-73. PMID 26768819 DOI: 10.1002/Anie.201507546  0.534
2016 Zhao L, Tang C, Xu L, Zhang Z, Li X, Hu H, Cheng S, Zhou W, Huang M, Fong A, Liu B, Tseng HR, Gao H, Liu Y, Fang X. Enhanced and Differential Capture of Circulating Tumor Cells from Lung Cancer Patients by Microfluidic Assays Using Aptamer Cocktail. Small (Weinheim An Der Bergstrasse, Germany). PMID 26763166 DOI: 10.1002/Smll.201503188  0.432
2016 Hou S, Choi JS, Garcia MA, Xing Y, Chen KJ, Chen YM, Jiang ZK, Ro T, Wu L, Stout DB, Tomlinson J, Wang H, Chen K, Tseng HR, Lin WY. Pretargeted Positron Emission Tomography Imaging that Employs Supramolecular Nanoparticles with in Vivo Bioorthogonal Chemistry. Acs Nano. PMID 26731174 DOI: 10.1021/Acsnano.5B06860  0.677
2016 Chen J, Ho H, Hodara E, Go A, Ureno A, Kaufman ET, Sievert M, Chung LW, Ke Z, Tseng H, Posadas EM. Very small nuclear circulating tumor cell (vsnCTC) as a putative biomarker for visceral metastasis in metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 34: 64-64. DOI: 10.1200/Jco.2016.34.2_Suppl.64  0.372
2016 Huynh R, Chen J, Tighiouart M, Sievert M, Oppenheim A, Moldawer NP, Knudsen B, Freeman M, Bhowmick N, Rogatko A, Tseng H, Chung LW, Scher K, Figlin RA, Posadas EM. A phase II study of cabozantinib in metastatic castration-resistant prostate cancer (mCRPC) with visceral metastases (VM) with very small nuclear circulating tumor cell (vsnCTC) association studies. Journal of Clinical Oncology. 34: 208-208. DOI: 10.1200/Jco.2016.34.2_Suppl.208  0.337
2016 Chen J, Ho H, Hodara E, Ureno A, Go A, Kaufman E, Sievert M, Luthringer DJ, Huang J, Chung L, Ke Z, Li K, Tseng H, Posadas EM. Abstract 4962: Very-small-nuclear circulating tumor cell (vsnCTC) as a putative biomarker for visceral metastasis in metastatic castration-resistant prostate cancer (mCRPC) Cancer Research. 76: 4962-4962. DOI: 10.1158/1538-7445.Am2016-4962  0.395
2015 Jiang R, Lu YT, Ho H, Li B, Chen JF, Lin M, Li F, Wu K, Wu H, Lichterman J, Wan H, Lu CL, OuYang W, Ni M, Wang L, ... ... Tseng HR, et al. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer. Oncotarget. PMID 26575023 DOI: 10.18632/Oncotarget.6330  0.418
2015 Court CM, Ankeny JS, Hou S, Tseng HR, Tomlinson JS. Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis. Expert Review of Molecular Diagnostics. 1-14. PMID 26390158 DOI: 10.1586/14737159.2015.1091311  0.416
2015 Chen JF, Ho H, Lichterman J, Lu YT, Zhang Y, Garcia MA, Chen SF, Liang AJ, Hodara E, Zhau HE, Hou S, Ahmed RS, Luthringer DJ, Huang J, Li KC, ... ... Tseng HR, et al. Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases. Cancer. PMID 25975562 DOI: 10.1002/Cncr.29455  0.644
2015 Hou S, Choi JS, Chen KJ, Zhang Y, Peng J, Garcia MA, Yu JH, Thakore-Shah K, Ro T, Chen JF, Peyda P, Fan G, Pyle AD, Wang H, Tseng HR. Supramolecular nanosubstrate-mediated delivery for reprogramming and transdifferentiation of Mammalian cells. Small (Weinheim An Der Bergstrasse, Germany). 11: 2499-504. PMID 25613059 DOI: 10.1002/Smll.201402602  0.655
2015 Ke Z, Lin M, Chen JF, Choi JS, Zhang Y, Fong A, Liang AJ, Chen SF, Li Q, Fang W, Zhang P, Garcia MA, Lee T, Song M, Lin HA, ... ... Tseng HR, et al. Programming thermoresponsiveness of NanoVelcro substrates enables effective purification of circulating tumor cells in lung cancer patients. Acs Nano. 9: 62-70. PMID 25495128 DOI: 10.1021/Nn5056282  0.639
2015 Lu Y, Chen J, Ho H, Lichterman J, Chung LW, Li K, Ke Z, Tseng H, Posadas EM. Subclassification of prostate cancer circulating tumor cells (CTCs) by nuclear size reveals very-small nuclear CTCs in patients with visceral metastases. Journal of Clinical Oncology. 33: 11027-11027. DOI: 10.1200/Jco.2015.33.15_Suppl.11027  0.391
2015 Chen J, Ho H, Lichterman J, Lu Y, Zhang Y, Garcia MA, Chen S, Liang A, Zhau HE, Hou S, Ahmed RS, Luthringer DJ, Huang J, Li K, Chung LW, ... ... Tseng H, et al. Abstract 3473: Sub-classification of prostate cancer circulating tumor cells (CTCs) by nuclear size reveals very-small nuclear CTCs in patients with visceral metastases Cancer Research. 75: 3473-3473. DOI: 10.1158/1538-7445.Am2015-3473  0.638
2014 Posadas EM, Tighiouart M, Lu Y, Di Vizio D, Hoffman D, Green L, Scher K, Sievert M, Oppenheim A, Moldawer N, Knudsen B, Freeman M, Bhowmick N, Rogatko A, Tseng H, et al. 1574PA TRANSLATIONAL PHASE 2 STUDY OF CABOZANTINIB IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER WITH VISCERAL METASTASES WITH CHARACTERIZATION OF CIRCULATING TUMOR CELLS AND LARGE ONCOSOMES. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv547. PMID 28171512 DOI: 10.1093/Annonc/Mdu358.5  0.38
2014 Lin M, Chen JF, Lu YT, Zhang Y, Song J, Hou S, Ke Z, Tseng HR. Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells. Accounts of Chemical Research. 47: 2941-50. PMID 25111636 DOI: 10.1021/Ar5001617  0.462
2014 Peng J, Garcia MA, Choi JS, Zhao L, Chen KJ, Bernstein JR, Peyda P, Hsiao YS, Liu KW, Lin WY, Pyle AD, Wang H, Hou S, Tseng HR. Molecular recognition enables nanosubstrate-mediated delivery of gene-encapsulated nanoparticles with high efficiency. Acs Nano. 8: 4621-9. PMID 24708312 DOI: 10.1021/Nn5003024  0.659
2014 Hsiao YS, Luo SC, Hou S, Zhu B, Sekine J, Kuo CW, Chueh DY, Yu HH, Tseng HR, Chen P. 3D bioelectronic interface: capturing circulating tumor cells onto conducting polymer-based micro/nanorod arrays with chemical and topographical control. Small (Weinheim An Der Bergstrasse, Germany). 10: 3012-7. PMID 24700425 DOI: 10.1002/Smll.201400429  0.391
2014 Ankeny JS, Hou S, Lin M, OuYang H, Song M, Rochefort MM, Girgis MD, Isacoff WH, Wainberg ZA, Tseng H, Tomlinson JS. Pancreatic circulating tumor cells as a diagnostic adjunct in pancreatic cancer. Journal of Clinical Oncology. 32: 175-175. DOI: 10.1200/Jco.2014.32.3_Suppl.175  0.392
2014 Posadas EM, Tighgohart M, Lu Y, Vizio DD, Hoffman DMJ, Green L, Sievert M, Oppenheim A, Moldawer NP, Knudsen B, Freeman M, Bhowmick N, Rogatko A, Tseng H, Chung LW, et al. A translational phase 2 study of cabozantinib in men with metastatic castration resistant prostate cancer with visceral metastases with characterization of circulating tumor cells and large oncosomes. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E16080  0.349
2014 Lu Y, Jiang R, Tseng H, Chung LW, Posadas EM. Abstract 938: Single-cell whole-genome sequencing verifies the surrogacy of circulating tumor cells for prostate cancer Cancer Research. 74: 938-938. DOI: 10.1158/1538-7445.Am2014-938  0.435
2014 Ankeny JS, Hou S, Lin M, Frias M, OuYang H, Song M, Rochefort MM, Girgis MD, Tseng H, Tomlinson JS. Abstract 3070: Capture, isolation, and mutational analysis of single pancreatic circulating tumor cells using NanoVelcro technology Cancer Research. 74: 3070-3070. DOI: 10.1158/1538-7445.Am2014-3070  0.421
2013 Lu YT, Zhao L, Shen Q, Garcia MA, Wu D, Hou S, Song M, Xu X, Ouyang WH, Ouyang WW, Lichterman J, Luo Z, Xuan X, Huang J, Chung LW, ... ... Tseng HR, et al. NanoVelcro Chip for CTC enumeration in prostate cancer patients. Methods (San Diego, Calif.). 64: 144-52. PMID 23816790 DOI: 10.1016/J.Ymeth.2013.06.019  0.631
2013 Zhao L, Lu YT, Li F, Wu K, Hou S, Yu J, Shen Q, Wu D, Song M, OuYang WH, Luo Z, Lee T, Fang X, Shao C, Xu X, ... ... Tseng HR, et al. High-purity prostate circulating tumor cell isolation by a polymer nanofiber-embedded microchip for whole exome sequencing. Advanced Materials (Deerfield Beach, Fla.). 25: 2897-902. PMID 23529932 DOI: 10.1002/Adma.201205237  0.652
2013 Lee JH, Chen KJ, Noh SH, Garcia MA, Wang H, Lin WY, Jeong H, Kong BJ, Stout DB, Cheon J, Tseng HR. On-demand drug release system for in vivo cancer treatment through self-assembled magnetic nanoparticles. Angewandte Chemie (International Ed. in English). 52: 4384-8. PMID 23519915 DOI: 10.1002/Anie.201207721  0.629
2013 Shen Q, Xu L, Zhao L, Wu D, Fan Y, Zhou Y, Ouyang WH, Xu X, Zhang Z, Song M, Lee T, Garcia MA, Xiong B, Hou S, Tseng HR, et al. Specific capture and release of circulating tumor cells using aptamer-modified nanosubstrates. Advanced Materials (Deerfield Beach, Fla.). 25: 2368-73. PMID 23495071 DOI: 10.1002/Adma.201300082  0.658
2013 Hou S, Zhao L, Shen Q, Yu J, Ng C, Kong X, Wu D, Song M, Shi X, Xu X, OuYang WH, He R, Zhao XZ, Lee T, Brunicardi FC, ... ... Tseng HR, et al. Polymer nanofiber-embedded microchips for detection, isolation, and molecular analysis of single circulating melanoma cells. Angewandte Chemie (International Ed. in English). 52: 3379-83. PMID 23436302 DOI: 10.1002/Anie.201208452  0.664
2013 Hou S, Zhao H, Zhao L, Shen Q, Wei KS, Suh DY, Nakao A, Garcia MA, Song M, Lee T, Xiong B, Luo SC, Tseng HR, Yu HH. Capture and stimulated release of circulating tumor cells on polymer-grafted silicon nanostructures. Advanced Materials (Deerfield Beach, Fla.). 25: 1547-51. PMID 23255101 DOI: 10.1002/Adma.201203185  0.673
2013 Hou S, Zhao L, Shen Q, Yu J, Ng C, Kong X, Wu D, Song M, Shi X, Xu X, OuYang W, He R, Zhao X, Lee T, Brunicardi FC, ... ... Tseng H, et al. Inside Back Cover: Polymer Nanofiber-Embedded Microchips for Detection, Isolation, and Molecular Analysis of Single Circulating Melanoma Cells (Angew. Chem. Int. Ed. 12/2013) Angewandte Chemie International Edition. 52: 3533-3533. DOI: 10.1002/Anie.201301082  0.596
2013 Hou S, Zhao L, Shen Q, Yu J, Ng C, Kong X, Wu D, Song M, Shi X, Xu X, OuYang W, He R, Zhao X, Lee T, Brunicardi FC, ... ... Tseng H, et al. Innenrücktitelbild: Polymer Nanofiber-Embedded Microchips for Detection, Isolation, and Molecular Analysis of Single Circulating Melanoma Cells (Angew. Chem. 12/2013) Angewandte Chemie. 125: 3619-3619. DOI: 10.1002/Ange.201301082  0.597
2013 Zhao L, Lu Y, Li F, Wu K, Hou S, Yu J, Shen Q, Wu D, Song M, OuYang W, Luo Z, Lee T, Fang X, Shao C, Xu X, ... ... Tseng H, et al. Tumor Cell Isolation: High-Purity Prostate Circulating Tumor Cell Isolation by a Polymer Nanofiber-Embedded Microchip for Whole Exome Sequencing (Adv. Mater. 21/2013) Advanced Materials. 25: 2870-2870. DOI: 10.1002/Adma.201370136  0.634
2013 Hou S, Zhao H, Zhao L, Shen Q, Wei KS, Suh DY, Nakao A, Garcia MA, Song M, Lee T, Xiong B, Luo S, Tseng H, Yu H. Cell Capture: Capture and Stimulated Release of Circulating Tumor Cells on Polymer-Grafted Silicon Nanostructures (Adv. Mater. 11/2013) Advanced Materials. 25: 1514-1514. DOI: 10.1002/Adma.201370069  0.614
2012 Chen KJ, Tang L, Garcia MA, Wang H, Lu H, Lin WY, Hou S, Yin Q, Shen CK, Cheng J, Tseng HR. The therapeutic efficacy of camptothecin-encapsulated supramolecular nanoparticles. Biomaterials. 33: 1162-9. PMID 22074663 DOI: 10.1016/J.Biomaterials.2011.10.044  0.66
2011 Sekine J, Luo SC, Wang S, Zhu B, Tseng HR, Yu HH. Functionalized conducting polymer nanodots for enhanced cell capturing: the synergistic effect of capture agents and nanostructures. Advanced Materials (Deerfield Beach, Fla.). 23: 4788-92. PMID 21954025 DOI: 10.1002/Adma.201102151  0.301
2011 Wang S, Owens GE, Tseng HR. Nano "fly paper" technology for the capture of circulating tumor cells. Methods in Molecular Biology (Clifton, N.J.). 726: 141-50. PMID 21424448 DOI: 10.1007/978-1-61779-052-2_10  0.408
2011 Wang S, Liu K, Liu J, Yu ZT, Xu X, Zhao L, Lee T, Lee EK, Reiss J, Lee YK, Chung LW, Huang J, Rettig M, Seligson D, Duraiswamy KN, ... ... Tseng HR, et al. Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers. Angewandte Chemie (International Ed. in English). 50: 3084-8. PMID 21374764 DOI: 10.1002/Anie.201005853  0.46
2011 Liu Y, Wang H, Kamei K, Yan M, Chen KJ, Yuan Q, Shi L, Lu Y, Tseng HR. Delivery of intact transcription factor by using self-assembled supramolecular nanoparticles. Angewandte Chemie (International Ed. in English). 50: 3058-62. PMID 21370360 DOI: 10.1002/Anie.201005740  0.521
2011 Chen KJ, Wolahan SM, Wang H, Hsu CH, Chang HW, Durazo A, Hwang LP, Garcia MA, Jiang ZK, Wu L, Lin YY, Tseng HR. A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity. Biomaterials. 32: 2160-5. PMID 21167594 DOI: 10.1016/J.Biomaterials.2010.11.043  0.647
2011 Kamei K, Sun J, Tseng HR, Damoiseaux R. Microfluidic image cytometry. Methods in Molecular Biology (Clifton, N.J.). 706: 191-206. PMID 21104065 DOI: 10.1007/978-1-61737-970-3_16  0.406
2011 Wang S, Liu K, Liu J, Yu ZT, Xu X, Zhao L, Lee T, Lee EK, Reiss J, Lee Y, Chung LWK, Huang J, Rettig M, Seligson D, Duraiswamy KN, ... ... Tseng H, et al. Cover Picture: Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers (Angew. Chem. Int. Ed. 13/2011) Angewandte Chemie International Edition. 50: 2857-2857. DOI: 10.1002/Anie.201100624  0.375
2011 Wang S, Liu K, Liu J, Yu ZT, Xu X, Zhao L, Lee T, Lee EK, Reiss J, Lee Y, Chung LWK, Huang J, Rettig M, Seligson D, Duraiswamy KN, ... ... Tseng H, et al. Titelbild: Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers (Angew. Chem. 13/2011) Angewandte Chemie. 123: 2909-2909. DOI: 10.1002/Ange.201100624  0.38
2010 Liu K, Wang H, Chen KJ, Guo F, Lin WY, Chen YC, Phung DL, Tseng HR, Shen CK. A digital microfluidic droplet generator produces self-assembled supramolecular nanoparticles for targeted cell imaging. Nanotechnology. 21: 445603. PMID 20935351 DOI: 10.1088/0957-4484/21/44/445603  0.518
2010 Wang H, Liu K, Chen KJ, Lu Y, Wang S, Lin WY, Guo F, Kamei K, Chen YC, Ohashi M, Wang M, Garcia MA, Zhao XZ, Shen CK, Tseng HR. A rapid pathway toward a superb gene delivery system: programming structural and functional diversity into a supramolecular nanoparticle library. Acs Nano. 4: 6235-43. PMID 20925389 DOI: 10.1021/Nn101908E  0.667
2010 Sun J, Masterman-Smith MD, Graham NA, Jiao J, Mottahedeh J, Laks DR, Ohashi M, DeJesus J, Kamei K, Lee KB, Wang H, Yu ZT, Lu YT, Hou S, Li K, ... ... Tseng HR, et al. A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens. Cancer Research. 70: 6128-38. PMID 20631065 DOI: 10.1158/0008-5472.Can-10-0076  0.398
2010 Wang S, Chen KJ, Wu TH, Wang H, Lin WY, Ohashi M, Chiou PY, Tseng HR. Photothermal effects of supramolecularly assembled gold nanoparticles for the targeted treatment of cancer cells. Angewandte Chemie (International Ed. in English). 49: 3777-81. PMID 20391446 DOI: 10.1002/Anie.201000062  0.525
2010 Kamei K, Ohashi M, Gschweng E, Ho Q, Suh J, Tang J, For Yu ZT, Clark AT, Pyle AD, Teitell MA, Lee KB, Witte ON, Tseng HR. Microfluidic image cytometry for quantitative single-cell profiling of human pluripotent stem cells in chemically defined conditions. Lab On a Chip. 10: 1113-9. PMID 20390128 DOI: 10.1039/B922884E  0.301
2010 Wang H, Chen KJ, Wang S, Ohashi M, Kamei K, Sun J, Ha JH, Liu K, Tseng HR. A small library of DNA-encapsulated supramolecular nanoparticles for targeted gene delivery. Chemical Communications (Cambridge, England). 46: 1851-3. PMID 20198230 DOI: 10.1039/B923711A  0.503
2010 Jung J, Solanki A, Memoli KA, Kamei K, Kim H, Drahl MA, Williams LJ, Tseng HR, Lee K. Selective inhibition of human brain tumor cells through multifunctional quantum-dot-based siRNA delivery. Angewandte Chemie (International Ed. in English). 49: 103-7. PMID 19950159 DOI: 10.1002/Anie.200905126  0.303
2009 Wang S, Wang H, Jiao J, Chen KJ, Owens GE, Kamei K, Sun J, Sherman DJ, Behrenbruch CP, Wu H, Tseng HR. Three-dimensional nanostructured substrates toward efficient capture of circulating tumor cells. Angewandte Chemie (International Ed. in English). 48: 8970-3. PMID 19847834 DOI: 10.1002/Anie.200901668  0.596
2009 Wang H, Wang S, Su H, Chen KJ, Armijo AL, Lin WY, Wang Y, Sun J, Kamei K, Czernin J, Radu CG, Tseng HR. A supramolecular approach for preparation of size-controlled nanoparticles. Angewandte Chemie (International Ed. in English). 48: 4344-8. PMID 19425037 DOI: 10.1002/anie.200900063  0.426
2009 Yu ZT, Kamei K, Takahashi H, Shu CJ, Wang X, He GW, Silverman R, Radu CG, Witte ON, Lee KB, Tseng HR. Integrated microfluidic devices for combinatorial cell-based assays. Biomedical Microdevices. 11: 547-55. PMID 19130244 DOI: 10.1007/S10544-008-9260-X  0.343
2007 Sui G, Lee CC, Kamei K, Li HJ, Wang JY, Wang J, Herschman HR, Tseng HR. A microfluidic platform for sequential ligand labeling and cell binding analysis. Biomedical Microdevices. 9: 301-5. PMID 17195108 DOI: 10.1007/S10544-006-9033-3  0.316
1999 Tseng H, Lee C, Yang L, Luh T. Umpolung Of Carbon-Sulfur Bonds. Novel Synthesis Of Substituted Allenes From Propargylic Dithioacetals Journal of Organic Chemistry. 64: 8582-8587. DOI: 10.1021/Jo991032B  0.493
1997 Tseng H, Luh T. Novel Coupling Reactions of Dithioacetals with Organocuprate Reagents. Propargylic Dithioacetal as an Allene−1,3-Zwitterion Synthon Journal of Organic Chemistry. 62: 4568-4569. DOI: 10.1021/Jo970700V  0.497
1996 Tseng H, Luh T. Propargylic Dithioacetal as an Allene 1,3-Dication Synthon. Nickel-Catalyzed Cross-Coupling Reactions of Propargylic Dithioacetals with Grignard Reagents† Journal of Organic Chemistry. 61: 8685-8686. DOI: 10.1021/Jo961514C  0.488
Show low-probability matches.